166 related articles for article (PubMed ID: 6276803)
1. Evidence that the effects of 5-hydroxytryptophan on the secretion of ACTH and growth hormone in dogs are not mediated by central release of serotonin.
Zimmermann H; Kaplan SL; Ganong WF
Neuroendocrinology; 1982 Jan; 34(1):27-31. PubMed ID: 6276803
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion.
Zimmermann H; Ganong WF
Neuroendocrinology; 1980; 30(2):101-7, 109. PubMed ID: 6986577
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs.
Richards GE; Holland FJ; Aubert ML; Ganong WF; Kaplan SL; Grumbach MM
Neuroendocrinology; 1980; 30(3):139-43. PubMed ID: 6767993
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
[TBL] [Abstract][Full Text] [Related]
5. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
Gartside SE; Cowen PJ
Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
[TBL] [Abstract][Full Text] [Related]
6. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.
Lovinger R; Holland J; Kaplan S; Grumbach M; Boryczka AT; Shackelford R; Salmon J; Reid IA; Ganong WF
Neuroscience; 1976 Dec; 1(6):443-50. PubMed ID: 11370235
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
Meyer JS; Buckholtz NS; Boggan WO
Neuroendocrinology; 1978; 26(5):312-24. PubMed ID: 150549
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
Lancranjan I; Wirz-Justice A; Pühringer W; Del Pozo E
J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
[TBL] [Abstract][Full Text] [Related]
10. Role of peripheral mechanisms in the behavioral effects of 5-hydroxytryptophan.
Carter RB; Dykstra LA; Leander JD; Appel JB
Pharmacol Biochem Behav; 1978 Aug; 9(2):249-53. PubMed ID: 309609
[TBL] [Abstract][Full Text] [Related]
11. Peripheral conversion of L-5-hydroxytryptophan to serotonin induces drinking in rats.
Kikta DC; Threatte RM; Barney CC; Fregly MJ; Greenleaf JE
Pharmacol Biochem Behav; 1981 Jun; 14(6):889-93. PubMed ID: 6973156
[TBL] [Abstract][Full Text] [Related]
12. Effects of serotonin and L-5-hydroxytryptophan on plasma renin activity in rats.
Barney CC; Threatte RM; Kikta DC; Fregly MJ
Pharmacol Biochem Behav; 1981 Jun; 14(6):895-900. PubMed ID: 7019933
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase.
Lindström P; Sehlin J
Endocrinology; 1983 Apr; 112(4):1524-9. PubMed ID: 6339207
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin.
Spinedi E; Gaillard RC
J Endocrinol Invest; 1991; 14(7):551-7. PubMed ID: 1658112
[TBL] [Abstract][Full Text] [Related]
15. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
Magnussen I; Jensen TS; Rand JH; Van Woert MH
Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
[TBL] [Abstract][Full Text] [Related]
16. Sites at which clonidine acts to affect blood pressure and the secretion of renin, growth hormone and ACTH.
Rudolph CD; Kaplan SL; Ganong WF
Neuroendocrinology; 1980 Aug; 31(2):121-8. PubMed ID: 6248808
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic glutamate levels following serotonergic stimulation: a pilot study using 7-Tesla magnetic resonance spectroscopy in healthy volunteers.
Jacobs GE; der Grond Jv; Teeuwisse WM; Langeveld TJ; van Pelt J; Verhagen JC; de Kam ML; Cohen AF; Zitman FG; van Gerven JM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):486-91. PubMed ID: 20138102
[TBL] [Abstract][Full Text] [Related]
18. The influence of serotonergic agents on the body temperature.
Pawlowski L
Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and 5-hydroxytryptophan on blood pressure and renal blood flow in anesthetized rats.
Ding XR; Stier CT; Itskovitz HD
Am J Med Sci; 1989 May; 297(5):290-3. PubMed ID: 2785758
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmitter regulation of growth hormone and ACTH in the rhesus monkey: effects of biogenic amines.
Chambers JW; Brown GM
Endocrinology; 1976 Feb; 98(2):420-8. PubMed ID: 2458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
